BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Palisade Bio readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of studies Palisade Bio's drugs run\, from C
 linicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07845487-32@assetmemo.bio
DTSTAMP:20261121T005449Z
DTSTART;VALUE=DATE:20271031
DTEND;VALUE=DATE:20271101
SUMMARY:PALI-2108: Phase 2 readout est. (NCT07845487)
DESCRIPTION:PALI-2108\, phase 2\, Ulcerative Colitis.\nStudy: A Trial to In
 vestigate PALI-2108 Versus Placebo in Participants With Moderately to Seve
 rely Active Ulcerative Colitis\nEstimated primary completion: October 2027
 . This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, a
 nd it can move.\nDrug page: https://assetmemo.bio/drug/pali-2108#upcoming-
 events\nRegistry record: https://clinicaltrials.gov/study/NCT07845487
URL:https://assetmemo.bio/drug/pali-2108#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
